PERSISTENCE OF REMISSION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER ADALIMUMAB THERAPY IS STOPPED: ECONOMIC IMPLICATIONS
Por:
Borras Blasco J, Cortes X, Fernandez S, Moles J and Castera M
Publicada:
1 nov 2015
Ahead of Print:
20 oct 2015
Resumen:
|